1. Home
  2. MIST vs ATLO Comparison

MIST vs ATLO Comparison

Compare MIST & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • ATLO
  • Stock Information
  • Founded
  • MIST 2003
  • ATLO 1903
  • Country
  • MIST Canada
  • ATLO United States
  • Employees
  • MIST N/A
  • ATLO N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • ATLO Major Banks
  • Sector
  • MIST Health Care
  • ATLO Finance
  • Exchange
  • MIST Nasdaq
  • ATLO Nasdaq
  • Market Cap
  • MIST 132.5M
  • ATLO 158.4M
  • IPO Year
  • MIST N/A
  • ATLO N/A
  • Fundamental
  • Price
  • MIST $1.43
  • ATLO $18.01
  • Analyst Decision
  • MIST Strong Buy
  • ATLO
  • Analyst Count
  • MIST 2
  • ATLO 0
  • Target Price
  • MIST $7.50
  • ATLO N/A
  • AVG Volume (30 Days)
  • MIST 2.9M
  • ATLO 14.5K
  • Earning Date
  • MIST 08-15-2025
  • ATLO 08-08-2025
  • Dividend Yield
  • MIST N/A
  • ATLO 4.83%
  • EPS Growth
  • MIST N/A
  • ATLO 43.60
  • EPS
  • MIST N/A
  • ATLO 1.53
  • Revenue
  • MIST N/A
  • ATLO $57,731,000.00
  • Revenue This Year
  • MIST N/A
  • ATLO N/A
  • Revenue Next Year
  • MIST N/A
  • ATLO N/A
  • P/E Ratio
  • MIST N/A
  • ATLO $11.81
  • Revenue Growth
  • MIST N/A
  • ATLO 12.59
  • 52 Week Low
  • MIST $0.63
  • ATLO $15.69
  • 52 Week High
  • MIST $2.75
  • ATLO $21.66
  • Technical
  • Relative Strength Index (RSI)
  • MIST 40.51
  • ATLO 47.42
  • Support Level
  • MIST $1.42
  • ATLO $17.90
  • Resistance Level
  • MIST $1.64
  • ATLO $18.91
  • Average True Range (ATR)
  • MIST 0.11
  • ATLO 0.37
  • MACD
  • MIST -0.03
  • ATLO -0.05
  • Stochastic Oscillator
  • MIST 8.95
  • ATLO 22.41

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.

Share on Social Networks: